Technology News and Research

RSS

IL-36 might be a useful therapeutic target in treatment of psoriasis

Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.

16 Oct 2012

Taking technology from the lab to the patient: SMART Arm™: Hand of hope for stroke survivors

Creating a viable commercial product from its beginnings as a research concept through to a final product patients can use is a long, difficult and often expensive process. However, as David Henderson, the Managing Director of UniQuest, one of the leading technology transfer companies in the Asia Pacific region explains, a focus on patient needs is vital for developing a successful product.

15 Oct 2012

Therapeutic HPV16 and HPV18 vaccine ‘may eliminate infection’

A candidate vaccine against human papillomavirus serotypes 16 and 18 appears to induce robust immune responses to antigens, potentially leading to the elimination of virus-infected cells and regression of dysplasia, say US investigators.

15 Oct 2012

Abertay lecture to reveal how computer games can help discover new drugs for cancer

How can computer games technology help discover new drugs to treat cancer? This surprising step forward for science will be revealed at a free public lecture at the University of Abertay Dundee this Wednesday at 6pm.

15 Oct 2012

AAPS recognizes top scientists in pharmaceutical sciences

During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following ground-breaking researchers with awards commemorating their contributions to the pharmaceutical sciences:

15 Oct 2012

Elekta Synergy system with Agility 160-leaf MLC now available at Radboud

The first of three newly acquired Elekta Synergy treatment systems equipped with Agility 160-leaf multi-leaf collimator (MLC) is now up and running clinically at Radboud University Nijmegen Medical Center - making the clinic the first in the Netherlands to use Agility.

From Elekta 15 Oct 2012

UK and USA healthcare systems can learn from each other

The healthcare systems of the USA and the UK are often thought of as polar opposites, yet the two countries may have much to learn from each other as they both embark upon significant health reforms, according to the authors of a Health Policy paper, published in The Lancet.

12 Oct 2012

Queen's chemists devise novel technique for rapid production of MOF porous materials

Chemists at Queen's University Belfast have devised a novel, environmentally friendly technique, which allows the rapid production of Metal-Organic Frameworks porous materials (MOFs).

12 Oct 2012

Perception test could predict mild cognitive impairment

Psychologists at the University of Toronto and the Georgia Institute of Technology - commonly known as Georgia Tech - have shown that an individual's inability to recognize once-familiar faces and objects may have as much to do with difficulty perceiving their distinct features as it does with the capacity to recall from memory.

12 Oct 2012

Sinai Hospital of Baltimore announces opening of new neurological rehabilitation center

Sinai Hospital of Baltimore announces the opening of the new Louis and Phyllis Friedman Neurological Rehabilitation Center. The 20-bed center located on the fifth floor of the hospital's South Tower provides specialized rehabilitation services to adults who have sustained a brain injury, stroke or other neurological disorder and is one of the most advanced facilities of its kind in the state.

12 Oct 2012

State roundup: Minn. says health exchange will cost $40 million

Minnesota budget officials estimate it could cost the state as much as $40 million to run its health insurance exchange in 2015. The state-based online insurance marketplaces are a cornerstone of the federal health care overhaul.

12 Oct 2012

ZELTIQ Aesthetics’ CoolCurve+ applicator to be highlighted at EMAA 2012

ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the 8th European Masters in Aesthetics & Anti-Aging (EMAA) in Paris, October 12-14, 2012, and will highlight CoolCurve+, the newest addition to the applicator platform for the CoolSculpting System.

12 Oct 2012

Bidirectional communication between breast cancer cells and nearby MSCs cause metastasis

In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, form what is known as the "tumor microenvironment."

12 Oct 2012

Alverix receives FDA 510(k) clearance for new BD Veritor System kit

Alverix, Inc., a world leader in the design and manufacture of next-generation platforms for diagnostic Point-of-Care (POC) testing, today announced that BD Diagnostics, a segment of Becton Dickinson and Company, a leading global medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD VeritorTM System for Rapid Detection of respiratory syncytial virus (RSV).

12 Oct 2012

Children exposed to natural playgrounds tend to be more active

Children who play on playgrounds that incorporate natural elements like logs and flowers tend to be more active than those who play on traditional playgrounds with metal and brightly colored equipment, according to a recent study from the University of Tennessee, Knoxville.

12 Oct 2012

Results from Aldagen’s ALD-401 Phase II trial on ischemic stroke

Early results of a Phase II intra-arterial stem cell trial for ischemic stroke showed no adverse events associated with the first 10 patients, allowing investigators to expand the study to a targeted total of 100 patients.

12 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

Longer looks: Mitt Romney's health care legacy; Closing of Philly hospitals brings 'grim consequences;' Young doctors and their apps

A journey into the places, people, and decisive moments that made the men who are competing for the presidency. ...As governor, Romney knew he needed what political pros called a "legacy issue" if he wanted to run for president one day. He devoted his energy towards reforming health care, an issue that Democrats had been grappling with and a problem that cost the state dearly as taxpayers bore the brunt of covering the uninsured.

11 Oct 2012

Retinal imaging holds clues to cause of brain injury in children

Retinal imaging can help differentiate intentional from accidental traumatic brain injury in children, suggests research.

11 Oct 2012

CEO Roundtable on Cancer's Life Sciences Consortium initiates Project Data Sphere

The CEO Roundtable on Cancer's Life Sciences Consortium has initiated Project Data Sphere, a collaborative effort to create a shared platform where clinical trials data will become available to researchers for further studies that will speed cancer research.

11 Oct 2012